Gene · 375790
Papers3,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perlecan, CollagenXVIII, and Agrin Expression in Normo-, Hypo-, and Aganglionic Segments in Hirschsprung's Disease. | Neurogastroenterol Motil | 2026 | 41555564 | PubTator, text mining | PubMed |
| Fiber-type-specific architecture and pathophysiology of the neuromuscular junction. | Neuroscience | 2026 | 41548740 | PubTator, text mining | PubMed |
| Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling. | Cell Death Dis | 2026 | 41535257 | PubTator, text mining | PubMed |
| Therapeutic Management in an AGRN-Related Congenital Myasthenic Syndrome Patient. | J Clin Neurol | 2026 | 41517821 | PubTator, text mining | PubMed |
| Muscle-specific tyrosine kinase activation by a peptide-based dimerizer is orientation dependent. | Structure | 2026 | 41290004 | PubTator, text mining | PubMed |
| A Combination of Whey Protein and Vitamin D Reduces Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. | Arch Med Res | 2026 | 41232427 | PubTator, text mining | PubMed |
| Asthma-chronic obstructive pulmonary disease overlap is associated with a higher degree of neuromuscular junction degradation than either disease alone. | Heart Lung | 2026 | 41046769 | PubTator, text mining | PubMed |
| Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus. | Br J Clin Pharmacol | 2026 | 40855709 | PubTator, text mining | PubMed |
| Identification of colorectal cancer molecular subtypes and prognostic features based on basement membrane-related genes. | J Appl Genet | 2026 | 40751879 | PubTator, text mining | PubMed |
| Exploring motor unit and neuromuscular junction dysfunction in aging and sarcopenia: insights from electromyography in systematic review. | Geroscience | 2026 | 40627125 | PubTator, text mining | PubMed |
| Neuromuscular junction instability with inactivity: morphological and functional changes after 10 days of bed rest in older adults. | J Physiol | 2026 | 40096637 | PubTator, text mining | PubMed |
| Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy. | Biomedicines | 2025 | 41462890 | PubTator, text mining | PubMed |
| Regulation of motor neuron differentiation in the Ciona larva. | bioRxiv | 2025 | 41446085 | PubTator, text mining | PubMed |
| Machine learning-driven comprehensive profiling of tumor heterogeneity and sialylation in hepatocellular carcinoma. | NPJ Precis Oncol | 2025 | 41408439 | PubTator, text mining | PubMed |
| Revealing Causal Protein Biomarkers and Potential Therapeutic Targets for Histologic-Specific Lung Cancer. | J Cell Mol Med | 2025 | 41340014 | PubTator, text mining | PubMed |
| Biomarkers Linked to Malnutrition Identified According to GLIM Criteria Among Older Community-Dwelling Adults: Results from the ilSIRENTE Study. | Nutrients | 2025 | 41305594 | PubTator, text mining | PubMed |
| Congenital myasthenic syndromes a rare case of AGRN mutation. | Am J Neurodegener Dis | 2025 | 41280347 | PubTator, text mining | PubMed |
| Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1. | J Cachexia Sarcopenia Muscle | 2025 | 41250834 | PubTator, text mining | PubMed |
| Nano- and Microscale Chemical and Topographical Patterning of Synthetic Cell Scaffolds: from Hard to Soft Materials. | ACS Mater Au | 2025 | 41245567 | PubTator, text mining | PubMed |
| An Investigation of the Levels of Serine Protease and Associated Molecules in Children with Autism Spectrum Disorder. | J Mol Neurosci | 2025 | 41039124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/375790/papers?page=4